Mercilon

Desogestrel, the active ingredient in Mercilon, is a combined oral contraceptive presented as an oral tablet for oral use. It works together with ethinylestradiol to prevent pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus.

GNH USA supplies Mercilon as a licensed, GDP‑compliant international pharmaceutical supplier, adhering to EU quality standards and providing the product to hospitals, pharmacies and clinics worldwide through regulated distribution channels. The company maintains robust logistics and ensures traceability from manufacturing to end‑user.

Mercilon, a combined oral contraceptive, is used within the hormonal contraception pathway to prevent pregnancy.

- Contraception: Prevents unintended pregnancy in women of childbearing potential. - Family planning: Provides reliable, reversible birth control for planned family size. - Menstrual cycle regulation: Helps achieve more predictable bleeding patterns during use.

Adverse reactions may occur with any hormonal contraceptive. Most are mild and transient, but serious events require immediate medical attention.

Common Side Effects: - Nausea: mild to moderate stomach upset, often transient. - Breast tenderness: discomfort or swelling of breast tissue. - Headache: occasional tension‑type or migraine‑like pain. - Spotting: irregular light bleeding between periods.

Serious or Rare Side Effects: - Thromboembolic events: deep vein thrombosis or pulmonary embolism. - Hypertension: new‑onset or worsening high blood pressure. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Liver dysfunction: jaundice or abnormal liver enzymes. - Visual disturbances: sudden vision changes or loss.

Before prescribing Mercilon, clinicians should evaluate individual risk factors and counsel patients on safe use.

- Medical evaluation: assess personal and family history of thromboembolism, cardiovascular disease, and liver disorders. - Smoking status: avoid use in women over 35 who smoke heavily. - Drug interactions: review concurrent medications that may reduce efficacy. - Pregnancy testing: confirm non‑pregnant status prior to initiation. - Breastfeeding: discuss alternative methods, as hormonal contraception may affect milk production. - Store at ambient temperature: keep tablets below 25°C in the original packaging, protected from moisture and light.

Mercilon can interact with several drug classes, altering its effectiveness or increasing risk of adverse events.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): markedly reduce contraceptive efficacy. - Certain antiretrovirals (e.g., efavirenz): may compromise hormone levels.

Moderate Interactions (Monitor Closely): - Antibiotics such as rifampin: may lower plasma concentrations of ethinylestradiol. - Herbal supplements (e.g., St. John’s wort): can decrease hormonal effectiveness. - Antifungal agents (e.g., griseofulvin): may modestly reduce contraceptive reliability.